Related references
Note: Only part of the references are listed.Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
Risk-Based Classification of Hypertension and the Role of Combination Therapy
Matthew R. Weir
JOURNAL OF CLINICAL HYPERTENSION (2008)
Cardiovascular protection using beta-blockers - A critical review of the evidence
Sripal Bangalore et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The vasoldilatory beta-blockers
Michala E. Pedersen et al.
CURRENT HYPERTENSION REPORTS (2007)
Body weight changes with β-blocker use:: Results from GEMINI
Franz H. Messerli et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension
Joanna Burns et al.
CIRCULATION (2007)
Profile of carvedilol control led-release: a new once-daily formulation of carvedilol
Gregg C. Fonarow
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Controlled-release carvedilol in the treatment of essential hypertension
Michael A. Weber et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatation
Robert Weiss
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Re-examining the efficacy of β-blockers for the treatment of hypertension:: a meta-analysis
N Khan et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
Arne H. Strand et al.
JOURNAL OF HYPERTENSION (2006)
Carvedilol action is dependent on endogenous production of nitric oxide
RA Afonso et al.
AMERICAN JOURNAL OF HYPERTENSION (2006)
Cardiac adrenoceptors: Physiological and pathophysiological relevance
Otto-Erich Brodde et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis
LH Lindholm et al.
LANCET (2005)
Causes and consequences of increased sympathetic activity in renal disease
JA Joles et al.
HYPERTENSION (2004)
Expert consensus document on β-adrenergic receptor blockers
J López-Sendón et al.
EUROPEAN HEART JOURNAL (2004)
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension - A randomized controlled trial
GL Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
β-blockers in hypertension:: Is carvedilol different?
FH Messerli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension
O Kamp et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
MR Law et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
